DuraSeal Exact Spine Sealant System Post-Approval Study

ClinicalTrials.gov ID: NCT01410864

Public ClinicalTrials.gov record NCT01410864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT01410864
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Integra LifeSciences Corporation; Industry
Enrollment: 924 participants

Conditions and interventions

Conditions

Dural Sealing

Interventions

DuraSeal Exact Spine Sealant System Device
Control Other

Device · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2011
Primary completion: Jun 30, 2016
Completion: Jun 30, 2016
Last update posted: Feb 28, 2017

2011 – 2016

United States locations

U.S. sites: 36
U.S. states: 24
U.S. cities: 34

Facility	City	State	ZIP	Site status
Not listed	Phoenix	Arizona	85023	—
Not listed	Los Angeles	California	90033	—
Not listed	Sacramento	California	95616	—
Not listed	San Francisco	California	94143	—
Not listed	San Jose	California	95128	—
Not listed	Stanford	California	94305	—
Not listed	Boulder	Colorado	80302	—
Not listed	Colorado Springs	Colorado	80907	—
Not listed	Denver	Colorado	80045	—
Not listed	Washington D.C.	District of Columbia	20037	—
Not listed	Tampa	Florida	33606	—
Not listed	Tampa	Florida	33637	—
Not listed	Atlanta	Georgia	30303	—
Not listed	Chicago	Illinois	60611	—
Not listed	Kansas City	Kansas	66160	—
Not listed	Louisville	Kentucky	40295	—
Not listed	New Orleans	Louisiana	70121	—
Not listed	Baltimore	Maryland	21211	—
Not listed	Boston	Massachusetts	02120	—
Not listed	Royal Oak	Michigan	48073	—
Not listed	St Louis	Missouri	63130	—
Not listed	Lebanon	New Hampshire	03766	—
Not listed	East Syracuse	New York	13057	—
Not listed	Charlotte	North Carolina	28207	—
Not listed	Durham	North Carolina	27708	—
Not listed	Cincinnati	Ohio	45219	—
Not listed	Cleveland	Ohio	44106	—
Not listed	Columbus	Ohio	43210	—
Not listed	Bend	Oregon	97701	—
Not listed	Philadelphia	Pennsylvania	19140	—
Not listed	Pittsburgh	Pennsylvania	15212	—
Not listed	Pittsburgh	Pennsylvania	15213	—
Not listed	Charleston	South Carolina	29406	—
Not listed	Plano	Texas	75093	—
Not listed	Charlottesville	Virginia	22903	—
Not listed	Seattle	Washington	98122	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01410864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 28, 2017 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01410864 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →